Contributions of the environment and environmentally vulnerable physiology to autism spectrum disorders
- PMID:20087183
- DOI: 10.1097/WCO.0b013e328336a01f
Contributions of the environment and environmentally vulnerable physiology to autism spectrum disorders
Abstract
Purpose of review: This review presents a rationale and evidence for contributions of environmental influences and environmentally vulnerable physiology to autism spectrum disorders (ASDs).
Recent findings: Recent studies suggest a substantial increase in ASD prevalence above earlier Centers for Disease Control figures of one in 150, only partly explicable by data artifacts, underscoring the possibility of environmental contributors to increased prevalence. Some gene variants in ASD confer altered vulnerability to environmental stressors and exposures. De-novo mutations and advanced parental age as a risk factor for ASD also suggest a role for environment. Systemic and central nervous system pathophysiology, including oxidative stress, neuroinflammation, and mitochondrial dysfunction can be consistent with a role for environmental influence (e.g. from air pollution, organophosphates, heavy metals) in ASD, and some of the underlying biochemical disturbances (such as abnormalities in glutathione, a critical antioxidant and detoxifier) can be reversed by targeted nutritional interventions. Dietary factors and food contaminants may contribute risk. Improvement and loss of diagnosis in some with ASD suggest brain circuitry amenable to environmental modulation.
Summary: Prevalence, genetic, exposure, and pathophysiological evidence all suggest a role for environmental factors in the inception and lifelong modulation of ASD. This supports the need for seeking targets for early and ongoing medical prevention and treatment of ASD.
Similar articles
- [Autism spectrum disorders--a syndrome on the rise: risk factors and advances in early detection and intervention].Zachor DA.Zachor DA.Harefuah. 2012 Mar;151(3):162-4, 189.Harefuah. 2012.PMID:22519265Hebrew.
- [The influence of genes and environment on the development of autism spectrum disorders].Spek AA.Spek AA.Tijdschr Psychiatr. 2014;56(10):660-7.Tijdschr Psychiatr. 2014.PMID:25327347Review.Dutch.
- Autism spectrum disorder and co-occurring developmental, psychiatric, and medical conditions among children in multiple populations of the United States.Levy SE, Giarelli E, Lee LC, Schieve LA, Kirby RS, Cunniff C, Nicholas J, Reaven J, Rice CE.Levy SE, et al.J Dev Behav Pediatr. 2010 May;31(4):267-75. doi: 10.1097/DBP.0b013e3181d5d03b.J Dev Behav Pediatr. 2010.PMID:20431403
- Is a subtype of autism an allergy of the brain?Theoharides TC.Theoharides TC.Clin Ther. 2013 May;35(5):584-91. doi: 10.1016/j.clinthera.2013.04.009.Clin Ther. 2013.PMID:23688533Review.
- Etiological heterogeneity in autism spectrum disorders: more than 100 genetic and genomic disorders and still counting.Betancur C.Betancur C.Brain Res. 2011 Mar 22;1380:42-77. doi: 10.1016/j.brainres.2010.11.078. Epub 2010 Dec 1.Brain Res. 2011.PMID:21129364Review.
Cited by
- Blood lead concentrations in Jamaican children with and without autism spectrum disorder.Rahbar MH, Samms-Vaughan M, Dickerson AS, Loveland KA, Ardjomand-Hessabi M, Bressler J, Shakespeare-Pellington S, Grove ML, Pearson DA, Boerwinkle E.Rahbar MH, et al.Int J Environ Res Public Health. 2014 Dec 23;12(1):83-105. doi: 10.3390/ijerph120100083.Int J Environ Res Public Health. 2014.PMID:25546274Free PMC article.
- Early environmental risk factors for neurodevelopmental disorders - a systematic review of twin and sibling studies.Carlsson T, Molander F, Taylor MJ, Jonsson U, Bölte S.Carlsson T, et al.Dev Psychopathol. 2021 Oct;33(4):1448-1495. doi: 10.1017/S0954579420000620.Dev Psychopathol. 2021.PMID:32703331Free PMC article.
- Evaluating Learning and Memory in Drosophila melanogaster to Study the Neurodevelopmental Impacts of Toxicants.Welch CJ, Mulligan KA.Welch CJ, et al.Curr Protoc. 2022 Oct;2(10):e576. doi: 10.1002/cpz1.576.Curr Protoc. 2022.PMID:36282085Free PMC article.
- Autologous bone marrow mononuclear cell therapy for autism: an open label proof of concept study.Sharma A, Gokulchandran N, Sane H, Nagrajan A, Paranjape A, Kulkarni P, Shetty A, Mishra P, Kali M, Biju H, Badhe P.Sharma A, et al.Stem Cells Int. 2013;2013:623875. doi: 10.1155/2013/623875. Epub 2013 Aug 25.Stem Cells Int. 2013.PMID:24062774Free PMC article.
- The promise and the pitfalls of autism research: an introductory note for new autism researchers.Amaral DG.Amaral DG.Brain Res. 2011 Mar 22;1380:3-9. doi: 10.1016/j.brainres.2010.11.077. Epub 2010 Dec 1.Brain Res. 2011.PMID:21129367Free PMC article.Review.
Publication types
MeSH terms
Related information
LinkOut - more resources
Full Text Sources
Research Materials